HIGHLIGHTS
- who: Lihui Wang from the DepartmentPharmaceutical University Army, Wuhan, China have published the research work: Cisplatin-enriching cancer stem cells confer multidrug resistance in non-small cell lung cancer via enhancing TRIB1/HDAC activity, in the Journal: (JOURNAL)
- how: Realtime cell analysis data indicated that only treatment with CDDP promoted cell migration as compared with DMSO control . ChIP assay and real-time PCR data indicated that CDDP-pretreated NCI-H460 cells exhibited a reduced binding ability of p53 to p21 promoter and displayed decreasing expression of p21 at mRNA level which Cell Death and . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.